BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 33652356)

  • 1. Alzheimer's disease and its treatment by different approaches: A review.
    Srivastava S; Ahmad R; Khare SK
    Eur J Med Chem; 2021 Apr; 216():113320. PubMed ID: 33652356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
    Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
    J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's Disease: Innovative Therapeutic Approaches Based on Peptides and Nanoparticles.
    Mota IFL; de Lima LS; Santana BM; Gobbo GAM; Bicca JVML; Azevedo JRM; Veras LG; Taveira RAA; Pinheiro GB; Mortari MR
    Neuroscientist; 2023 Feb; 29(1):78-96. PubMed ID: 34018874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-mediated approaches for Alzheimer's disease pathogenesis, diagnosis, and therapeutics.
    Hettiarachchi SD; Zhou Y; Seven E; Lakshmana MK; Kaushik AK; Chand HS; Leblanc RM
    J Control Release; 2019 Nov; 314():125-140. PubMed ID: 31647979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Progress in the Pharmacotherapy of Alzheimer's Disease.
    Khoury R; Patel K; Gold J; Hinds S; Grossberg GT
    Drugs Aging; 2017 Nov; 34(11):811-820. PubMed ID: 29116600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease: current status of etiopathogenesis and therapeutic strategies.
    Khairallah MI; Kassem LA
    Pak J Biol Sci; 2011 Feb; 14(4):257-72. PubMed ID: 21870628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches.
    Cruz-Vicente P; Passarinha LA; Silvestre S; Gallardo E
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33920326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's Disease Targeted Nano-Based Drug Delivery Systems.
    Altinoglu G; Adali T
    Curr Drug Targets; 2020; 21(7):628-646. PubMed ID: 31744447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future therapy in Alzheimer's disease.
    van Marum RJ
    Fundam Clin Pharmacol; 2008 Jun; 22(3):265-74. PubMed ID: 18485144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease.
    Karthivashan G; Ganesan P; Park SY; Kim JS; Choi DK
    Drug Deliv; 2018 Nov; 25(1):307-320. PubMed ID: 29350055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease.
    Ling TS; Chandrasegaran S; Xuan LZ; Suan TL; Elaine E; Nathan DV; Chai YH; Gunasekaran B; Salvamani S
    Biomed Res Int; 2021; 2021():5550938. PubMed ID: 34285915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene therapy and Alzheimer's disease].
    Li J; Li W; Zhou J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 40(4):428-32. PubMed ID: 25931222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.
    Ahmad J; Akhter S; Rizwanullah M; Khan MA; Pigeon L; Addo RT; Greig NH; Midoux P; Pichon C; Kamal MA
    Curr Alzheimer Res; 2017; 14(11):1164-1181. PubMed ID: 28482786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
    Sahni JK; Doggui S; Ali J; Baboota S; Dao L; Ramassamy C
    J Control Release; 2011 Jun; 152(2):208-31. PubMed ID: 21134407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology in the diagnostic and therapy for Alzheimer's disease.
    Panghal A; Flora SJS
    Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130559. PubMed ID: 38191034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier.
    Wong KH; Riaz MK; Xie Y; Zhang X; Liu Q; Chen H; Bian Z; Chen X; Lu A; Yang Z
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease.
    Kulshreshtha A; Piplani P
    Neurol Sci; 2016 Sep; 37(9):1403-35. PubMed ID: 27250365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease.
    Gupta J; Fatima MT; Islam Z; Khan RH; Uversky VN; Salahuddin P
    Int J Biol Macromol; 2019 Jun; 130():515-526. PubMed ID: 30826404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease.
    Madav Y; Wairkar S; Prabhakar B
    Brain Res Bull; 2019 Mar; 146():171-184. PubMed ID: 30634016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.